Quantitative structure-activity relationship studies of vitamin D receptor affinity for analogues of 1alpha,25-dihydroxyvitamin D3. 1: WHIM descriptors.

The weighted holistic invariant molecular (WHIM) approach has been applied to the study of the VDR affinity of 86 vitamin D analogues. A model able to describe more than 71% of the variance in the experimental activity was developed with the use of the mentioned approach. In contrast, none of three different approaches, including the use of BCUT, Galvez topological charge indices, and 2D autocorrelations descriptors, was able to explain more than 38% of the variance in the mentioned property, even with more variables in the equation.

[1]  M. Ohmori,et al.  Design and Efficient Synthesis of 2α-(ω-Hydroxyalkoxy)-1α,25-dihydroxyvitamin D3 Analogues, Including 2-epi-ED-71 and Their 20-Epimers with HL-60 Cell Differentiation Activity , 2004 .

[2]  Aliuska Morales Helguera,et al.  TOPS-MODE based QSARs derived from heterogeneous series of compounds. Applications to the design of new anti-inflammatory compounds. , 2004, Bioorganic & medicinal chemistry.

[3]  K. Nakagawa,et al.  Highly potent cell differentiation-inducing analogues of 1alpha,25-dihydroxyvitamin D3: synthesis and biological activity of 2-methyl-1,25-dihydroxyvitamin D3 with side-chain modifications. , 2001, Bioorganic & medicinal chemistry.

[4]  H. DeLuca,et al.  Synthesis, biological evaluation, and conformational analysis of A-ring diastereomers of 2-methyl-1,25-dihydroxyvitamin D(3) and their 20-epimers: unique activity profiles depending on the stereochemistry of the A-ring and at C-20. , 2000, Journal of medicinal chemistry.

[5]  N. Miyata,et al.  Synthesis and biological evaluation of all A-ring stereoisomers of 5,6-trans-2-methyl-1,25-dihydroxyvitamin D3 and their 20-epimers: possible binding modes of potent A-ring analogues to vitamin D receptor , 2001 .

[6]  R. Bouillon,et al.  Structure-function relationships in the vitamin D endocrine system. , 1995, Endocrine reviews.

[7]  Roberto Todeschini,et al.  Handbook of Molecular Descriptors , 2002 .

[8]  K. Waku,et al.  Efficient synthesis of 2-modified 1alpha,25-dihydroxy-19-norvitamin D3 with Julia olefination: high potency in induction of differentiation on HL-60 cells. , 2003, The Journal of organic chemistry.

[9]  J. Gálvez,et al.  New bronchodilators selected by molecular topology. , 1998, Bioorganic & medicinal chemistry letters.

[10]  Maykel Pérez González,et al.  QSAR study of N6-(substituted-phenylcarbamoyl) adenosine-5′-uronamides as agonist for A1 adenosine receptors , 2004 .

[11]  W. Okamura,et al.  Synthesis of Vitamin D (Calciferol) , 1995 .

[12]  C. Mathieu,et al.  Recent developments in the use of vitamin D analogues , 2000, Expert opinion on investigational drugs.

[13]  Keiko Yamamoto,et al.  Three-dimensional structure-function relationship of vitamin D and vitamin D receptor model , 2001, Steroids.

[14]  Milan Randić,et al.  Correlation of enthalphy of octanes with orthogonal connectivity indices , 1991 .

[15]  Maykel Pérez González,et al.  Quantitative structure-activity relationship to predict differential inhibition of aldose reductase by flavonoid compounds. , 2005, Bioorganic & medicinal chemistry.

[16]  I. Azumaya,et al.  Design and synthesis of potent vitamin D receptor antagonists with A-ring modifications: remarkable effects of 2alpha-methyl introduction on antagonistic activity. , 2003, Bioorganic & medicinal chemistry.

[17]  Keiko Yamamoto,et al.  Rational design, synthesis, and biological activity of novel conformationally restricted vitamin D analogues, (22R)- and (22S)-22-ethyl-1,25-dihydroxy-23,24-didehydro-24a,24b-dihomo-20-epivitamin D(3). , 2002, Journal of medicinal chemistry.

[18]  S. Kato,et al.  Synthesis of 2,2-dimethyl-1,25-dihydroxyvitamin D3: A-ring structural motif that modulates interactions of vitamin D receptor with transcriptional coactivators. , 2003, Organic & biomolecular chemistry.

[19]  Anthony W. Norman,et al.  Vitamin D : chemistry, biology and clinical applications of the steroid hormone : proceedings of the Tenth Workshop on Vitamin D, Strasbourg, France, May 24-29, 1997 , 1997 .

[20]  Maykel Pérez González,et al.  A TOPS-MODE approach to predict adenosine kinase inhibition. , 2004, Bioorganic & medicinal chemistry letters.

[21]  Maykel Pérez González,et al.  A radial distribution function approach to predict A(2B) agonist effect of adenosine analogues. , 2005, Bioorganic & medicinal chemistry.

[22]  Maykel Pérez González,et al.  A novel approach to predict a toxicological property of aromatic compounds in the Tetrahymena pyriformis. , 2004, Bioorganic & medicinal chemistry.

[23]  K. Waku,et al.  2,2-Functionalized analogues of 1α,25-dihydroxyvitamin D3, the potent inducers of cell differentiation , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[24]  K. Waku,et al.  Synthesis and testing of 2α-modified 1α, 25-dihydroxyvitamin D3 analogues with a double side chain: Marked cell differentiation activity , 2002 .

[25]  Eamonn F. Healy,et al.  Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model , 1985 .

[26]  K. Umesono,et al.  The nuclear receptor superfamily: The second decade , 1995, Cell.

[27]  J. Pike,et al.  Vitamin D3 receptors: structure and function in transcription. , 1991, Annual review of nutrition.

[28]  Maykel Pérez González,et al.  A TOPS-MODE approach to predict affinity for A1 adenosine receptors. 2-(Arylamino)adenosine analogues. , 2004, Bioorganic & medicinal chemistry.

[29]  Maykel Pérez González,et al.  A topological substructural approach applied to the computational prediction of rodent carcinogenicity. , 2005, Bioorganic & medicinal chemistry.

[30]  H. DeLuca,et al.  Stereoselective syntheses of (22R)- and (22S)-22-methyl-1.alpha.,25-dihydroxyvitamin D3: active vitamin D3 analogs with restricted side-chain conformation , 1993 .

[31]  A. Kutner,et al.  Convergent synthesis, chiral HPLC, and vitamin D receptor affinity of analogs of 1,25-dihydroxycholecalciferol. , 1999, Chirality.

[32]  Maykel Pérez González,et al.  Quantitative structure-activity relationship to predict toxicological properties of benzene derivative compounds. , 2005, Bioorganic & medicinal chemistry.

[33]  Milan Randic,et al.  Resolution of ambiguities in structure-property studies by use of orthogonal descriptors , 1991, J. Chem. Inf. Comput. Sci..

[34]  K. Waku,et al.  Concise synthesis and biological activities of 2α-Alkyl- and 2α-(ω-Hydroxyalkyl)-20- epi -1α,25-dihydroxyvitamin D 3 , 2003 .

[35]  Maykel Pérez González,et al.  Geometry, topology, and atom-weights assembly descriptors to predicting A1 adenosine receptors agonists. , 2005, Bioorganic & medicinal chemistry letters.

[36]  Eugenio Uriarte,et al.  Stochastic-based descriptors studying peptides biological properties: modeling the bitter tasting threshold of dipeptides. , 2004, Bioorganic & medicinal chemistry.

[37]  S. Yamada,et al.  Conformation-function relationship of vitamin D: conformational analysis predicts potential side-chain structure. , 1998, Journal of medicinal chemistry.

[38]  Milan Randic,et al.  Orthogonal molecular descriptors , 1991 .

[39]  K. Nakagawa,et al.  Efficient synthesis and biological evaluation of all A-ring diastereomers of 1alpha,25-dihydroxyvitamin D3 and its 20-epimer. , 2000, Bioorganic & medicinal chemistry.